I know that pharmaceutical companies had to invest a lot of money in the research of antipsychotics, and chemists certainly synthesized hundreds and maybe even thousands of chemical substances in laboratory experiments, and then tested them on animals (which is quite enough) and later on humans. Certainly, pharmacology is not so well developed in all areas of medicine, and not as much money has been invested in it as in atypical antipsychotics. However, atypical antipsychotics do not always have an advantage – they act on many types of receptors, which may not always be good, and typical antipsychotics also have their advantages.
The problem, however, is rather the lack of certain medicines on the Slovak market. This is the fault of the State Institute for Drug Control (ŠÚKL), which should do everything possible to ensure that as many pharmaceutical companies as possible register their medicines in the Slovak Republic. ŠÚKL should participate in world pharmaceutical exhibitions and try to attract as many companies as possible to Slovakia. (In addition, through price competition, the health insurance company would save a lot of money).
And another problem is that psychiatrists themselves do not understand the drugs they prescribe, and they should definitely understand them.
I consider it unreasonable if one patient is prescribed two antipsychotics. The drugs will first block each other's effects on some receptors, which in practice can be counterproductive.
According to current knowledge, dopamine, serotonin, and histamine (you heard right, histamine) and muscarinic-acetylcholine receptors are responsible for schizophrenia. If they act on histamine receptors, they always act antagonistically. Antipsychotics act on serotonin receptors either as agonists or antagonists.
Furthermore, I think it is a big mistake for a doctor to be guided by package inserts, as there is too little information. The choice of drug should always be based on the receptors that the drug acts on. For example, with serotonin receptors, it is most complex: the individual types of receptors differ significantly from each other.
The following drug, an antipsychotic, is also very unconventional (in that it acts on a small number of receptor types). It is a histamine and serotonin antagonist. It also has anti-anxiety effects.
Hydroxyzine (Atarax)
https://en.wikipedia.org/wiki/Hydroxyzine
************
The most common mistake psychiatrists make with psychiatric patients is prescribing them a large number of drugs, which is completely counterproductive, as the effects of the drugs can block each other and so on. In general, a patient should not take more than one antipsychotic. Pharmaceutical companies have invested extremely large sums of money in atypical antipsychotics, and they are unique in that they act on a large number of receptors. Only a few psychiatrists understand the effects of the drugs they prescribe (this would require studying something in English, not just package inserts and the poor professional medical journal Solen). Some antipsychotics are agonists on serotonin receptors, meaning they also have antidepressant effects, and such patients do not even need to be prescribed serotonin antidepressants. Antipsychotics can be roughly divided into the following types, all of which are available on the modest Slovak pharmaceutical market: selective dopamine receptor antagonist (e.g., sulpiride), serotonin and dopamine antagonist (risperidone), serotonin agonist dopamine antagonist (e.g., quetiapine), serotonin and dopamine agonist (Aripiprazole – this will probably be a better antidepressant than an antipsychotic).